1. Signaling Pathways
  2. Others
  3. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (9621):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W012480S1
    DL-Tryptophan-d8
    99.64%
    DL-Tryptophan-d8 is the deuterium labeled DL-Tryptophan. DL-Tryptophan is an endogenous metabolite.
    DL-Tryptophan-d<sub>8</sub>
  • HY-A0132S10
    N-Acetyl-D-glucosamine-13C2,15N
    N-Acetyl-D-glucosamine-13C2,15N is the 13C and 15N labeled N-Acetyl-D-glucosamine. N-Acetyl-D-Glucosamine (N-Acetyl-2-amino-2-deoxy-D-glucose) is a monosaccharide derivative of gluc.
    N-Acetyl-D-glucosamine-<sup>13</sup>C<sub>2</sub>,<sup>15</sup>N
  • HY-115702S
    1-Palmityl-2-O-acetyl-3-glyceryl phosphorylcholine-d4
    ≥99.0%
    1-Palmityl-2-O-acetyl-3-glyceryl phosphorylcholine-d4 is the deuterium labeled 1-Palmityl-2-O-acetyl-3-glyceryl phosphorylcholine.
    1-Palmityl-2-O-acetyl-3-glyceryl phosphorylcholine-d<sub>4</sub>
  • HY-14779S
    Riociguat-13C,d6
    ≥99.0%
    Riociguat-13C,d6 is the 13C and deuterium labeled Riociguat (HY-14779). Riociguat is an oral stimulator of soluble guanylate cyclase (sGC) used in the treatment of pulmonary hypertension.
    Riociguat-<sup>13</sup>C,d<sub>6</sub>
  • HY-W127834
    Disulfiram-d20
    99.7%
    Disulfiram-d20 is deuterium labeled Disulfiram-d20.
    Disulfiram-d20
  • HY-B0167S1
    Salicylic acid-13C6
    Salicylic acid-13C6 is the 13C-labeled Salicylic acid (HY-B0167). Salicylic acid is a precursor to and a metabolite of Aspirin (HY-14654), can inhibit cyclo-oxygenase-2 (COX-2) activity.
    Salicylic acid-<sup>13</sup>C<sub>6</sub>
  • HY-113424AS
    1,2-Dioleoyl-sn-glycero-3-phosphocholine-d9
    ≥98.0%
    1,2-Dioleoyl-sn-glycero-3-phosphocholine-d9 is deuterium labeled 1,2-Dioleoyl-sn-glycero-3-phosphocholine. 1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC) is a phospholipid and is commonly used alone, or with other components, in the generation of micelle
    1,2-Dioleoyl-sn-glycero-3-phosphocholine-d<sub>9</sub>
  • HY-128735S
    N-Formylglycine-d2
    N-Formylglycine-d2 is the deuterated labeled N-Formylglycine (HY-128735). N-Formylglycine is an endogenous metabolite.
    N-Formylglycine-d<sub>2</sub>
  • HY-113371AS
    2-Methylcitric acid-d3 trisodium
    2-Methylcitric acid-d3 (Methylcitric acid-d3) trisodium is deuterium-labeled 2-Methylcitric acid (trisodium) (HY-113371A).
    2-Methylcitric acid-d<sub>3</sub> trisodium
  • HY-107372S2
    Uridine triphosphate-13C9 dilithium
    ≥98.0%
    Uridine triphosphate-13C9 (UTP-13C9 dilithium; Uridine 5'-triphosphate-13C9) dilithium is 13C-labeled Uridine triphosphate (HY-107372). Uridine triphosphate (UTP;Uridine 5'-triphosphate) is a nucleotide that regulates the functions of the pancreas in endocrine and exocrine secretion, proliferation, channels, transporters, and intracellular signaling under normal and disease states.
    Uridine triphosphate-<sup>13</sup>C<sub>9</sub> dilithium
  • HY-N0019S1
    Daidzein-d6
    Daidzein-d6 is a deuterium labeled Daidzein (HY-N0019). Daidzein is a soy isoflavone, which acts as a PPAR activator.
    Daidzein-d<sub>6</sub>
  • HY-D0184S3
    2'-Deoxycytidine-13C9,15N3
    99.00%
    2'-Deoxycytidine-13C9,15N3 (Deoxycytidine-13C9,15N3; Cytosine deoxyriboside-13C9,15N3; Deoxyribose cytidine-13C9,15N3) is 13C and 15N-labeled 2'-Deoxycytidine (HY-D0184). 2'-Deoxycytidine, a deoxyribonucleoside, could inhibit biological effects of Bromodeoxyuridine (Brdu).
    2'-Deoxycytidine-<sup>13</sup>C<sub>9</sub>,<sup>15</sup>N<sub>3</sub>
  • HY-133588S
    4-Formylaminoantipyrine-d3
    99.71%
    4-Formylaminoantipyrine-d3 is the deuterium labeled 4-Formylaminoantipyrine (HY-133588). 4-Formylaminoantipyrine is an excreted metabolite of Aminophenazone. Aminophenazone is a pyrazolone with analgesic, anti-inflammatory, and antipyretic effects in vivo.
    4-Formylaminoantipyrine-d<sub>3</sub>
  • HY-17504S
    Rosuvastatin-d6 calcium
    98.54%
    Rosuvastatin-d6 (calcium) is deuterium labeled Rosuvastatin.
    Rosuvastatin-d<sub>6</sub> calcium
  • HY-W654078
    Bisphenol AF-13C12
    99.24%
    Bisphenol AF-13C12 is an isotopic label of Bisphenol AF. Bisphenol AF is used in polycarbonate plastic and epoxy resin manufacturing. Bisphenol AF can significantly increase intracellular ROS levels.
    Bisphenol AF-<sup>13</sup>C<sub>12</sub>
  • HY-W012510S
    2,4-Dichlorobenzoic acid-d3
    2,4-Dichlorobenzoic acid-d3 is the deuterium labeled 2,4-Dichlorobenzoic acid.
    2,4-Dichlorobenzoic acid-d<sub>3</sub>
  • HY-17538AS
    ZLN005-d4 hydrochloride
    ZLN005-d4 hydrochloride is the deuterium labeled ZLN005.
    ZLN005-d<sub>4</sub> hydrochloride
  • HY-146930S
    16:1 SM (d18:1/16:1)-d9
    16:1 SM (d18:1/16:1)-d9 is deuterium labeled 16:1 SM (d18:1/16:1).
    16:1 SM (d18:1/16:1)-d<sub>9</sub>
  • HY-10569S
    Ponesimod-d4
    Ponesimod-d4 (ACT-128800-d4) is the deuterium labeled Ponesimod (HY-10569). Ponesimod (ACT-128800) is a potent, selective and orally active agonist of S1P1, with an IC50 of 6 nM in a radioligand binding assay. Ponesimod activates S1P1-mediated signal transduction with high potency (EC50=5.7 nM). Ponesimod can protect against lymphocyte-mediated tissue inflammation.
    Ponesimod-d<sub>4</sub>
  • HY-108321S
    Zofenopril-d5
    99.92%
    Zofenopril-d5 is deuterium labeled Zofenopril. Zofenopril is an angiotensin-converting enzyme (ACE) inhibitor with an IC50 of 81 μM.
    Zofenopril-d<sub>5</sub>